Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polidocanol foam sclerotherapy for venous malformations and macrocystic lymphatic malformations
jRCTs031230604Active, not recruiting
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Open-label, single-arm trial of 10XB101 in venous malformation (VM) and lymphatic malformation (LM). Started Feb 2024; status: active, not recruiting.
02
Drugs
10XB101
03
Conditions
venous malformation (VM)lymphatic malformation (LM)
Beyond the preview
Go deeper on jRCTs031230604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230604.